Featured image of the article A look back at mRNA patenting activity for 2023.

A look back at mRNA patenting activity for 2023

SOPHIA ANTIPOLIS, France – January 16, 2024 │ The last quarterly report for the 2023 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. As we leave behind another year, we look back on the mRNA therapeutic patenting activity! Q4 2023[…]

Acuitas Therapeutics filed a complaint against CureVac SE seeking inventorship: Pfizer & BioNtech potentially in the crosshairs

SOPHIA ANTIPOLIS, France – November 27, 2023 │Acuitas Therapeutics filed a complaint on November 13, 2023, against CureVac SE seeking a declaratory judgment of inventorship regarding the US patents 11,241,493; 11,471,525; 11,576,966; and 11,596,686 (collectively referred to as Patent Family ‘493). According to the complaint (Case 3:23-cv-00764), the patents in question were wrongfully assigned to[…]

ReNAgade Therapeutics unveiled new LNPs for delivering mRNA to extra-hepatic tissues: Patent analysis on its proprietary ionizable lipids

SOPHIA ANTIPOLIS, France – November 06, 2023 │ReNAgadeTherapeutics, a company founded in 2021 and based in Cambridge, presented preclinical data demonstrating a new and proprietary method of delivering mRNA to extra-hepatic tissues in non-human primate using lipid nanoparticles (LNPs) at the 11th International mRNA Health Conference, taking place from October 31 to November 2, 2023[…]

Cellectis is a strategic intellectual property partner for AstraZeneca in the field of off-the-shelf immunotherapies

SOPHIA ANTIPOLIS, France – November 02, 2023 │Cellectis and AstraZeneca announced their partnership through a Joint Research Collaboration Agreement, an $80 million initial equity investment, and a memorandum of understanding for an additional $140 million equity investment. The focus of this collaboration is to advance the development of cutting-edge treatments for critical medical conditions in[…]